{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:45:09Z","timestamp":1777520709162,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.jaad.2007.05.024","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T07:22:43Z","timestamp":1182496963000},"page":"622-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris"],"prefix":"10.1016","volume":"57","author":[{"given":"Cheyda","family":"Chams-Davatchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafiseh","family":"Esmaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Daneshpazhooh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahin","family":"Valikhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Balighi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Hallaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Barzegari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Akhyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Zahra","family":"Ghodsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Seirafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Javad","family":"Tabrizi Nazemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Mirshams-Shahshahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.05.024_bib1","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.0022-202X.2004.23930.x","article-title":"IVIg treatment of pemphigus: how it works and how to use it","volume":"125","author":"Bystryn","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib2","first-page":"377","article-title":"Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris","volume":"13","author":"Sami","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/mjd.2002.122735","article-title":"Treatment of pemphigus with intravenous immunoglobulin","volume":"47","author":"Bystryn","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib4","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archderm.138.9.1158","article-title":"Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris","volume":"138","author":"Sami","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1468-3083.2006.01540.x","article-title":"The role of IVIg treatment in severe pemphigus","volume":"20","author":"Baum","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2007.05.024_bib6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2133.2005.06651.x","article-title":"Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus","volume":"153","author":"Arin","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0001-7310(06)73348-8","article-title":"Treatment of severe refractory pemphigus vulgaris with rituximab","volume":"97","author":"Pitarch","year":"2006","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2007.05.024_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000090659","article-title":"Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein- reactive autoantibodies by immunoadsorption","volume":"212","author":"Eming","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.05.024_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1196\/annals.1361.103","article-title":"Treatment of pemphigus vulgaris with protein A immunoadsorption: case report of long-term history showing favorable outcome","volume":"1051","author":"Frost","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jaad.2007.05.024_bib10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0190-9622(03)02738-5","article-title":"Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris","volume":"49","author":"Mimouni","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib11","first-page":"347","article-title":"Epitope spreading: a mechanism for progression of autoimmune disease","volume":"48","author":"Tuohy","year":"2000","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jaad.2007.05.024_bib12","first-page":"868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus","volume":"136","author":"Ionnides","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib13","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.1988.01670110019004","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib14","first-page":"570","article-title":"Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPLUS trial","volume":"142","author":"Mentik","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib15","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-4362.1994.tb01003.x","article-title":"Treatment of oral pemphigus vulgaris","volume":"33","author":"Chrysomallis","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus. an update","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib18","first-page":"926","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harmann","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","article-title":"Azathioprine in the treatment of pemphigus vulgaris: a long-term follow-up","volume":"16","author":"Aberer","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0190-9622(96)80066-1","article-title":"Influence of treatment on the clinical course of pemphigus vulgaris","volume":"34","author":"Carson","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2133.2003.05269.x","article-title":"An evaluation of the usefulness of mycophenolate mofetil in pemphigus","volume":"149","author":"Powell","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archderm.135.1.54","article-title":"Mycophenolate is effective in the treatment of pemphigus vulgaris","volume":"135","author":"Enk","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.139.6.739","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil","volume":"139","author":"Mimouni","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib24","first-page":"23","article-title":"[Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris.]","volume":"129","author":"Chams-Davatchi","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2007.05.024_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.135.1.57","article-title":"Pulse intravenous cyclophosphamide therapy in pemphigus","volume":"135","author":"Fleischli","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.05.024_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-199142050-00005","article-title":"Cyclophosphamide toxicity: characterizing and avoiding the problem","volume":"42","author":"Fraiser","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2007.05.024_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000057886","article-title":"Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus","volume":"204","author":"Kanwar","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.05.024_bib28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1067\/S0190-9622(03)00859-4","article-title":"Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus","volume":"49","author":"Cummins","year":"2003","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207008900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207008900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:10Z","timestamp":1759270090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207008900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0190962207008900"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.05.024","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1088527.541598","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1088527.793493615","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}